Linked Data API

Show Search Form

Search Results

819161
registered interest true more like this
date less than 2018-01-09more like thisremove minimum value filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care remove filter
hansard heading Influenza: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives from (a) GPs, (b) patient organisations and (c) manufacturers on the availability of the new enhanced influenza vaccine for the over-65s for the 2017-18 and the 2018-19 season. more like this
tabling member constituency Rother Valley more like this
tabling member printed
Sir Kevin Barron more like this
uin 121838 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-01-15more like thismore than 2018-01-15
answer text <p>Officials at the Department and Public Health England have regular discussions with manufacturers on a range of issues. This has included discussion with Seqirus, the company that has produced the new adjuvanted trivalent flu vaccine (aTIV).</p><p> </p><p>Officials have had no discussions with general practitioner representatives or patient groups on the aTIV.</p><p> </p><p>Officials also attend meetings of the Joint Committee on Vaccination and Immunisation, which includes a lay member.</p><p><strong> </strong></p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-01-15T17:51:33.653Zmore like thismore than 2018-01-15T17:51:33.653Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
392
label Biography information for Sir Kevin Barron more like this